Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BALLAD UK adjuvant chemotherapy trial in small bowel adenocarcinoma
2013-003047-29Phase 3Unknown
- Sponsor
- NHS Greater Glasgow and Clyde
- Start
- Jan 2015
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of fluorouracil, folinic acid, capecitabine and oxaliplatin in small bowel adenocarcinoma (SBA) (3 arms), sponsored by NHS Greater Glasgow and Clyde. Primary endpoint: Disease-free survival. Status: unknown.
02
Drugs
fluorouracilfolinic acidcapecitabineoxaliplatin
03
Conditions
small bowel adenocarcinoma (SBA)
Beyond the preview
Go deeper on 2013-003047-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003047-29.